Back
Solid Biosciences Vs. Perspective Therapeutics Industry Stock Comparison
Sell
17
SLDB
Solid Biosciences
Last Price:
5.53
Seasonality Move:
38.41%
Sell
30
CATX
Perspective Therapeutics
Last Price:
11.93
Seasonality Move:
28.84%
Sell
17
Solid Biosciences (SLDB)
is a Sell
Is Solid Biosciences a Buy, Sell or Hold?
- The current Solid Biosciences [SLDB] share price is $5.74. The Score for SLDB is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- SLDB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $11.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SLDB Stock Price Chart
What is Solid Biosciences's stock price today?
-
The Solid Biosciences share price today is $5.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLDB is experiencing slight selling pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $11.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
SLDB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.44 | Sell |
Relative Strength Index (14 RSI): | 38.72 | Sell |
Chaikin Money Flow: | -106243 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.82 - 6.9) | Sell |
Bollinger Bands (100): | (6.34 - 8.72) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.47 | Sell |
Relative Strength Index (14 RSI): | 38.27 | Sell |
Chaikin Money Flow: | -240035 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.98 - 13.14) | Sell |
Bollinger Bands (100): | (11.25 - 14.35) | Sell |
SLDB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.72 | Buy |
20-day SMA: | 6.22 | Sell |
50-day SMA: | 7.34 | Sell |
200-day SMA: | 8.62 | Sell |
8-day EMA: | 5.83 | Sell |
20-day EMA: | 6.22 | Sell |
50-day EMA: | 6.94 | Sell |
200-day EMA: | 7.6 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.93 | Sell |
20-day SMA: | 12.55 | Sell |
50-day SMA: | 13.63 | Sell |
200-day SMA: | 12.48 | Sell |
8-day EMA: | 11.92 | Sell |
20-day EMA: | 12.4 | Sell |
50-day EMA: | 12.94 | Sell |
200-day EMA: | 11.76 | Sell |
Solid Biosciences Earnings Growth & SLDB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.12 per share, and an increase next year of $0.14 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.
Solid Biosciences Technical Analysis
Oct 17 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |